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Acute lower motor neuron syndrome and
spinal cord gray matter hyperintensities in
HIV infection
ABSTRACT
Objective: To describe a novel manifestation of lower motor neuron disease in patients with well-
controlled HIV infection.
Methods: A retrospective study was performed to identify HIV-positive individuals with acute,
painful lower motor neuron diseases.
Results: Six patients were identified with HIV and lower motor neuron disease. Two patients met
the inclusion criteria of well-controlled, chronic HIV infection and an acute, painful, unilateral
lower motor neuron paralytic syndrome affecting the distal portion of the upper limb. These pa-
tients had segmental T2-hyperintense lesions in the central gray matter of the cervical spinal
cord on MRI. One patient stabilized and the second patient improved with immunomodulatory
therapy.
Conclusions: This newly described syndrome expands the clinical spectrum of lower motor
neuron diseases in HIV. Neurol Neuroimmunol Neuroinflamm 2015;2:e113; doi: 10.1212/
NXI.0000000000000113
GLOSSARY
ALS 5 amyotrophic lateral sclerosis; ART 5 antiretroviral therapy; BAD 5 brachial amyotrophic diplegia; Ig 5 immunoglob-
ulin; LMN 5 lower motor neuron.
Lower motor neuron (LMN) diseases related to HIV are rare and frequently mimic amyotrophic
lateral sclerosis (ALS).1 This syndrome of muscle atrophy and weakness is typically subacute and
responds to antiretroviral therapy (ART). Here we describe 2 cases of an HIV-related motor
neuron syndrome characterized by an acute, painful, unilateral segmental cervical motor neu-
ronopathy affecting predominantly the distal portion of the upper limb in virologically sup-
pressed individuals. In both cases, MRI of the cervical spinal cord disclosed segmental
T2-hyperintense lesions in the central gray matter.
METHODS A retrospective study was performed with permission from the Partners Research Ethics Board. We searched our online
medical database for cases of LMN disease in the context of HIV infection at the Massachusetts General Hospital between July 1996
and July 2011. Inclusion criteria included HIV infection, LMN disease, acute onset of symptoms, and a painful, unilateral syndrome.
Identified charts were reviewed in detail and responses to therapy were documented.
RESULTS Six patients with HIV infection and LMN disease were identified. Four patients were excluded
because they did not meet inclusion criteria—all demonstrated a bilateral process at presentation and had
no pain. The 2 patients that met inclusion criteria are described in detail below.
Patient 1. A 62-year-old man presented in March 2009 with new, rapidly worsening left hand weakness
heralded by left scapular pain that radiated down the upper arm and forearm and into his hand. Two days
after the onset of pain, severe weakness developed in the fingers, wrist, and forearm, resulting in a flaccid
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paralysis of his hand. The pain resolved in a few days,
but his weakness persisted. There were no other
motor, sensory, or constitutional symptoms, and
there was no history of trauma or medication changes.
The patient was diagnosed with HIV in 2006, at
which time his viral load was greater than 500,000
copies/mL and his CD4 count was 4 cells/mL. At
the time of his HIV diagnosis, examination of the left
upper extremity demonstrated dystonia of the hand,
atrophy and fasciculations in the deltoid and biceps,
and an absent biceps reflex consistent with an LMN
syndrome of the C5 and C6 myotomes. Cervical
spine MRI revealed multilevel discogenic degenera-
tive arthropathy with lateral and central canal steno-
ses. In addition, there were unusual symmetrical
nonenhancing areas of T2-hyperintense signal local-
ized to the central gray matter of the cord at C3-C4
and C6-C7 (figure, A and B). Because the spondy-
lotic changes did not fully explain the clinical syn-
drome and the central cord myelopathic changes,
neurosurgery deferred cervical decompression. No
evidence for opportunistic infections was found.
Indeed, the left hand dystonia resolved dramatically
and the atrophy and fasciculations in the arm dimin-
ished markedly within months of initiating ART con-
sisting of tenofovir, emtricitabine, and efavirenz.
The neurologic examination performed at the
time of his 2009 presentation for left upper extremity
pain and weakness was significant for a power grade
of 0/5 for left finger abduction and adduction, finger
extension and flexion, and thumb abduction and
opposition. Left elbow extension was graded at 2/5
with fully preserved elbow flexion strength. Upper
extremity reflexes were absent bilaterally. Fascicula-
tions were seen in the left biceps and deltoid muscles,
as before. There were no sensory deficits in the left
upper limb. The rest of the neurologic examination,
including gait and balance, was normal. Cervical
spine MRI was unchanged from 2006, with no signif-
icant worsening of the degenerative disc disease and
persistent gray matter abnormalities at C3-C4 and
C6-C7 (figure, A and B). Brain MRI was normal.
Nerve conduction and EMG studies performed 24
days after onset of weakness demonstrated a severely
reduced left median motor response with prolonged
distal motor latency, slowed median motor conduc-
tion velocity, and prolonged F-wave latency, all of
which were considered commensurate with the loss
of fast-conducting motor fibers or their motor neu-
rons. The left ulnar response was also severely
reduced. (The right median and ulnar motor conduc-
tion studies, including F-wave latencies, were nor-
mal.) There was no evidence for significant sensory
dysfunction or partial motor conduction block. Cou-
pled with the needle electrode examination showing
severe acute denervation in the left C8 and T1 my-
otomes, the findings were consistent with segmental
anterior horn cell injury at the level of the cervical
spinal cord. Serum HIV load was undetectable, and
CD4 cell count was 150 cells/mL. Both levels had
been stable for more than 2 years. CSF was not tested.
The clinical and EMG findings correlated with the
gray matter lesions at the level of the C7 vertebral
body, as this corresponds to the C8 and T1 segments
of the cord. Given a possible parainfectious or auto-
immune mechanism, he was empirically treated with
prednisone 60 mg/day for 1 week, along with occu-
pational and physical therapy. Left hand strength
after 6 weeks had improved to 2/5 in finger flexion,
extension, abduction, and adduction but eventually
regressed to total paralysis.
In July 2010, the patient presented with new right
hand pain and weakness progressing over 4 days
accompanied by sharp pain in the right shoulder
and arm. Neurologic examination showed weakness
of the right hand with power grade 3/5 for finger flex-
ion, 2/5 for finger abduction and adduction, and 2/5
for thumb abduction and opposition. The left hand
remained paralyzed. Reflexes were 11 in the upper
extremities. Strength was preserved at the deltoids,
biceps, and triceps bilaterally, with occasional fasci-
culations in the deltoid and biceps muscles, as before.
The rest of his neurologic examination was normal.
Cervical spine MRI was unchanged except for
some mild cord atrophy at C4-C5 and C6-C7 where
the T2-hyperintense gray matter abnormalities per-
sisted. Nerve conduction studies of the right median,
ulnar, and radial nerves, and the medial and lateral
Figure Spinal cord imaging
(A, B) Sagittal and axial T2-weighted cervical spine MRI
demonstrating hyperintensities in the central gray matter
of patient 1 (arrows). (C, D) Sagittal and axial T2-weighted
cervical spine MRI demonstrating hyperintensities in the
central gray matter of patient 2 (arrows).
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antebrachial cutaneous nerves disclosed normal re-
sponses, whereas the right median, ulnar, and radial
motor responses were moderately to markedly
reduced. The needle examination disclosed active
and chronic denervation changes in a multisegmental
(C5-C6, C7, and C8) distribution, a pattern of find-
ings that localized to the motor portion of the periph-
eral nervous system proximal to the dorsal root
ganglia—a cervical polyradiculopathy or segmental
myelopathy. SerumHIV load remained undetectable,
and the CD4 count was 161 cells/mL. CSF revealed 3
white blood cells, glucose 75 mg/dL, and protein 86
mg/dL (normal range 55 mg/dL) without organisms
on stains and culture. CSF PCR for JC virus, HIV,
enteroviruses, varicella-zoster virus, herpes simplex
virus, and Epstein-Barr virus was negative. There
was no serologic evidence of hepatitis B, hepatitis
C, or syphilis. Serum vitamin B12 was normal. Rheu-
matoid factor, antinuclear, and double-stranded
DNA antibodies were negative. Serum immunoglob-
ulin (Ig) levels were normal. Stool sample for polio-
virus by PCR was negative.
Reasoning that the pathophysiology was parain-
fectious or autoimmune (similar to the 2009 epi-
sode), the patient was treated for 5 days with IVIg.
The deterioration of hand strength abated, and 6
weeks later right finger abduction and adduction,
thumb abduction and opposition, and finger flexion
and extension improved to 3/5 strength. His exami-
nation remained unchanged 12 months later.
Patient 2. A 53-year-old man was evaluated in
October 2010 for 2 months of progressive
numbness and pain in the left 4th and 5th fingers
extending to the elbow. The pain was severe and
woke him from sleep but gradually subsided as his
hand weakness became obvious. There were no other
neurologic or systemic symptoms.
His HIV infection, diagnosed in 1997, had been
well-controlled on an ART regimen consisting of dar-
unavir, ritonavir, and tenofovir/emtricitabine for 4
years. CD4 counts were greater than 500 cells/mL,
and viral loads had been undetectable for more than
1 year. He had failed interferon therapy for his hepa-
titis C infection in 2003. He had not used IV drugs
for 6 years.
The only prior neurologic history was in 2000
when he was evaluated for daily episodes of paresthe-
sia extending from the left shoulder to the hand last-
ing from seconds to minutes and often accompanied
by weakness in the arm. Cervical spine MRI showed
multilevel degenerative arthropathy and disc disease
without central canal stenosis. An unexpected focus
of intramedullary central gray matter T2 hyperinten-
sity was also found at the C5 vertebral body level
(more prominent ventrally) and was not associated
with cord expansion (figure, C and D). His symp-
toms resolved spontaneously over a few months.
In 2010, the neurologic abnormalities were lim-
ited to the left upper extremity, with 4/5 weakness
in finger abduction and adduction, finger extension,
and thumb abduction and opposition. There was
no focal muscular wasting or fasciculations. Upper
extremity reflexes were 21 and symmetric. There
was a slight decrease of sensation to light touch, pin-
prick, and vibration sense in the palmar aspect of the
left 4th and 5th fingers. There were no long tract
signs in the lower limbs other than a right upgoing
toe. Gait and balance were normal. Cervical spine
mobility was normal.
At the time of examination, serum HIV was unde-
tectable and the CD4 count was 600 cells/mL. Serum
vitamin B12, C-reactive protein, erythrocyte sedimen-
tation rate, and angiotensin-converting enzyme were
within normal limits. Serum tests for rheumatoid
factor, cryoglobulins, antinuclear, and extractable
nuclear antigens were negative; anti-treponemal anti-
bodies were negative. Serum Ig electrophoresis was
normal. CSF demonstrated no white blood cells, glu-
cose 64 mg/dL, and protein 31 mg/dL, with no or-
ganisms visualized or cultured. CSF Venereal Disease
Research Laboratory was negative. CSF PCRs for
Epstein-Barr virus, herpes simplex virus, varicella-
zoster virus, JC virus, cytomegalovirus, HIV, and
West Nile virus were negative. PCR for poliovirus
was negative in a stool sample.
MRI showed enlargement of the bilateral nonen-
hancing gray matter T2 hyperintensity at C5 and a
new lesion extending from C6-T1 (figure, C and
D). Nerve conduction studies were performed 2
months after the onset of symptoms. Sensory studies
of the left median, ulnar, and radial nerves, and the
lateral and medial antebrachial cutaneous nerves dis-
closed normal responses; the left median and ulnar
motor responses were also normal. The needle exam-
ination disclosed active denervation and reduced
motor unit potential recruitment in left upper limb
muscles (ulnar-supplied first dorsal interosseus and
radial-supplied extensor indicis proprius and extensor
digitorum communis) deriving innervations from the
C7 and C8 cervical segments (left cervical paraspinal
muscles also showed active denervation changes).
These changes were consistent with the presence of
a cervical polyradiculopathy or segmental cervical
myelopathy.
The subacute LMN syndrome was again felt to be
parainfectious or autoimmune and related to HIV
because no alternative etiology could be identified.
He was treated with IVIg 400 mg/kg/day for 4 days,
monthly for 12 months. The severe pain in the left
upper limb and the sensory changes disappeared
within 2 weeks. By 6 months, hand strength was full,
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and there was no recurrence of symptoms in the fol-
lowing 2 years. The T2-hyperintense signals in the
cervical cord MRI at the C5 and C6 levels had not
changed on repeat imaging 6 months later.
DISCUSSION HIV-related motor neuron disorders
were first described in 1985 and remain a rare mani-
festation of HIV infection. Motor neuron syndromes
in HIV-positive individuals can mimic ALS, and
ALS-like syndromes are more common in HIV-
positive patients than the general population.2–4 An
immune-mediated mechanism is suspected, as
neurons are not known to be infected by HIV.5,6 A
rare LMN disorder known as brachial amyotrophic
diplegia (BAD) has also been described in HIV-
positive patients, including those with undetectable
viral loads.7–9 It is characterized by gradually progressive
proximal upper extremity weakness and wasting and is
also referred to as “flail arm syndrome.”10,11 LMN
disease is more common when HIV infection is
poorly controlled and symptoms stabilize or reverse
after ART initiation, as occurred in our first patient
before his subsequent decline 2 years later.2
Although 2 HIV-positive patients with BAD have
been reported to have gray matter spinal cord abnor-
malities on MRI, the patients described in this report
had rapidly evolving neurologic syndromes character-
ized by distal upper limb weakness heralded by
pain.7,9 The clinical, electrophysiologic, and neuro-
imaging characteristics of the patients we report
may be conceptualized as an acute segmental cervical
poliomyelopathy. The upper limb pain and weakness
experienced by our patients led us to consider the
possibility that they might have had a manifestation
of brachial plexus neuropathy or neuralgic amyotro-
phy (i.e., Parsonage-Turner syndrome), as has been
described in HIV-infected patients.12,13 In both pa-
tients, however, there was conspicuous sparing of sen-
sory responses that are normally subserved by
pathways derived from all portions of the brachial
plexus. These spared sensory responses in the setting
of marked motor axon loss (as manifested by attenu-
ation of motor responses and active and chronic
denervation in a multisegmental distribution in
patient 1 and the involvement of the C7 and C8
segments with paraspinal involvement in patient 2)
would be unusual in a brachial plexus lesion. Indeed,
in lesions of the brachial plexus, attenuation or loss of
sensory responses is very common14 and is considered
to provide “one of the most useful pieces of informa-
tion to help differentiate plexus from root lesions.”15
In contrast, the sparing of sensory responses in the
patients reported here strongly suggests a pregangli-
onic site of pathology to explain the clinical features
and correlates with the presence of spinal cord signal
changes onMRI. The clinical picture described in our
report is reminiscent of poliomyelitis; however, there
were no inflammatory changes in the CSF and the
CSF enterovirus PCRs and stool PCR for poliovirus
were negative. Lastly, it is important to contrast this
syndrome with HIV vacuolar myelopathy, a late man-
ifestation of AIDS that presents as progressive spastic
paraparesis and ataxia coupled with bowel and blad-
der dysfunction over a period of months.
It is important to note that both patients’ MRI
abnormalities were chronic and were associated ini-
tially with mild clinical abnormalities. The 2 episodes
of acute weakness in the first patient and the single
event of subacute weakness in the second patient were
superimposed on a preexisting gray matter myelopa-
thy. Another notable factor is that the limb weakness
in each episode was unilateral while the MRI changes
were bilateral. This, along with chronic low-grade
LMN signs of fasciculations in the proximal segments
of the upper arms in the first patient, points to an
acute-on-chronic motor neuron injury. The late seg-
mental cord atrophy in the first patient is indicative of
tissue loss as a result of this process. A confounding
issue is the substantial multilevel cervical spondylosis
resulting in foraminal and central canal stenoses. This
process may have predisposed the patients to a seg-
mental LMN disorder.
The underlying pathogenesis of this described
LMN disorder in our patients is unknown. It is nota-
ble that the neurologic condition appeared while the
patients were on stable ART regimens with undetect-
able serum HIV by PCR and stable CD4 counts. No
evidence of opportunistic infections was found, espe-
cially for neurotropic viruses. HIV escape into the
CNS was excluded by finding an undetectable HIV
load in the CSF. We suspected an indirect (e.g., para-
infectious) effect of HIV infection on the cervical
cord motor neurons and possibly the motor nerve
roots by a putative autoimmune mechanism. This
was the basis for empiric treatment with prednisone
and IVIg. This treatment strategy was associated with
clinical stabilization in the first patient and recovery
in the second patient. In summary, we describe 2
virally suppressed patients whose clinical, electrophys-
iologic, neuroimaging, and treatment response
expand the spectrum of motor neuron diseases associ-
ated with HIV.
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